These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8. Decroos C; Clausen DJ; Haines BE; Wiest O; Williams RM; Christianson DW Biochemistry; 2015 Mar; 54(12):2126-35. PubMed ID: 25793284 [TBL] [Abstract][Full Text] [Related]
3. Investigation of HDAC8-ligands' intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents. Dewaker V; Srivastava AK; Arora A; Prabhakar YS J Biomol Struct Dyn; 2021 Aug; 39(13):4726-4751. PubMed ID: 32578494 [TBL] [Abstract][Full Text] [Related]
4. The Importance of Structural Water in HDAC8 for Correct Binding Pose Applied for Drug Design of Anticancer Molecules. Morales-Herrejón G; Mendoza-Figueroa HL; Martínez-Archundía M; Correa-Basurto J Anticancer Agents Med Chem; 2024; 24(15):1109-1125. PubMed ID: 38835122 [TBL] [Abstract][Full Text] [Related]
5. Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases. Cole KE; Dowling DP; Boone MA; Phillips AJ; Christianson DW J Am Chem Soc; 2011 Aug; 133(32):12474-7. PubMed ID: 21790156 [TBL] [Abstract][Full Text] [Related]
6. Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation. Uba AI; Weako J; Keskin Ö; Gürsoy A; Yelekçi K J Biomol Struct Dyn; 2020 Apr; 38(6):1751-1760. PubMed ID: 31057077 [TBL] [Abstract][Full Text] [Related]
7. Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies. Zhou H; Wang C; Deng T; Tao R; Li W J Biomol Struct Dyn; 2018 Jun; 36(8):1966-1978. PubMed ID: 28632421 [TBL] [Abstract][Full Text] [Related]
9. Exploring the potential binding sites of some known HDAC inhibitors on some HDAC8 conformers by docking studies. Sixto-López Y; Gómez-Vidal JA; Correa-Basurto J Appl Biochem Biotechnol; 2014 Aug; 173(7):1907-26. PubMed ID: 24888409 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of c7-demethyl largazole analogues. Chen F; Gao AH; Li J; Nan FJ ChemMedChem; 2009 Aug; 4(8):1269-72. PubMed ID: 19431162 [No Abstract] [Full Text] [Related]
11. Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships. Poli G; Di Fabio R; Ferrante L; Summa V; Botta M ChemMedChem; 2017 Dec; 12(23):1917-1926. PubMed ID: 29117473 [TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors. Reddy DN; Ballante F; Chuang T; Pirolli A; Marrocco B; Marshall GR J Med Chem; 2016 Feb; 59(4):1613-33. PubMed ID: 26681404 [TBL] [Abstract][Full Text] [Related]
13. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies. Kashyap K; Kakkar R J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630 [TBL] [Abstract][Full Text] [Related]
14. Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue. Almaliti J; Al-Hamashi AA; Negmeldin AT; Hanigan CL; Perera L; Pflum MK; Casero RA; Tillekeratne LM J Med Chem; 2016 Dec; 59(23):10642-10660. PubMed ID: 27809521 [TBL] [Abstract][Full Text] [Related]
15. Largazole and analogues with modified metal-binding motifs targeting histone deacetylases: synthesis and biological evaluation. Bhansali P; Hanigan CL; Casero RA; Tillekeratne LM J Med Chem; 2011 Nov; 54(21):7453-63. PubMed ID: 21936551 [TBL] [Abstract][Full Text] [Related]
16. A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors. Hassanzadeh M; Bagherzadeh K; Amanlou M J Mol Graph Model; 2016 Nov; 70():170-180. PubMed ID: 27750186 [TBL] [Abstract][Full Text] [Related]
17. Potent non-hydroxamate inhibitors of histone deacetylase-8: Role and scope of an isoindolin-2-yl linker with an α-amino amide as the zinc-binding unit. Greenwood SOR; Chan AWE; Hansen DF; Marson CM Bioorg Med Chem Lett; 2020 Mar; 30(5):126926. PubMed ID: 31952961 [TBL] [Abstract][Full Text] [Related]
18. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using Paul M; Kumar Panda M; Thatoi H J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165 [TBL] [Abstract][Full Text] [Related]
19. Thiol versus hydroxamate as zinc binding group in HDAC inhibition: An ab initio QM/MM molecular dynamics study. Gong W; Wu R; Zhang Y J Comput Chem; 2015 Nov; 36(30):2228-35. PubMed ID: 26452222 [TBL] [Abstract][Full Text] [Related]
20. Thermodynamics of binding of structurally similar ligands to histone deacetylase 8 sheds light on challenges in the rational design of potent and isozyme-selective inhibitors of the enzyme. Singh RK; Suzuki T; Mandal T; Balsubramanian N; Haldar M; Mueller DJ; Strode JA; Cook G; Mallik S; Srivastava DK Biochemistry; 2014 Dec; 53(48):7445-58. PubMed ID: 25407689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]